IPO registrations (S-1, F-1) · Registrants
RetinalGenix Technologies Inc.
- SEC CIK
- 1836295 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2021-08-05, last 2022-01-26; 2 initial registrations, 2 amendments
- Outcome
- Declared effective 2021-10-07
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 1450 NORTH MCDOWELL BOULEVARD, SUITE 150, Petaluma, CA 94954
- EIN
- 82-3936890
- Ticker
- RTGN (OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- RetinalGenix Technologies Inc. on the corporate pages
Offering terms
- Shares offered
- 1,259,368
- Listing
- OTC under the symbol RTGN
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: RETINALGENIX TECHNOLOGIES INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form D issuer: RetinalGenix Technologies Inc. EXACT (CIK (EXACT))
- SEC filer: RETINALGENIX TECHNOLOGIES INC. EXACT (CIK (EXACT))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-08-05 | S-1 | S-1 (registration) | RetinalGenix Technologies Inc. | 0001493152-21-018775 ↗ |
| 2021-10-01 | S-1/A | S-1/A (amendment) | RetinalGenix Technologies Inc. | 0001493152-21-024382 ↗ |
| 2021-10-07 | EFFECT | EFFECT (declared effective) | RetinalGenix Technologies Inc. | 9999999995-21-003814 ↗ |
| 2022-01-21 | S-1 | S-1 (registration) | RetinalGenix Technologies Inc. | 0001493152-22-001956 ↗ |
| 2022-01-26 | S-1/A | S-1/A (amendment) | RetinalGenix Technologies Inc. | 0001493152-22-002285 ↗ |
| 2022-01-31 | EFFECT | EFFECT (declared effective) | RetinalGenix Technologies Inc. | 9999999995-22-000291 ↗ |
| 2022-06-08 | EFFECT | EFFECT (declared effective) | RetinalGenix Technologies Inc. | 9999999995-22-001726 ↗ |
| 2022-06-21 | EFFECT | EFFECT (declared effective) | RetinalGenix Technologies Inc. | 9999999995-22-001823 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-26 | S-1/A | registration statement | 1,259,368 | - | OTC RTGN | 0 | primary document; shares headline | document ↗ |
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-02-09 | RetinalGenix Technologies Inc. | Biotechnology | $5,000,000 | $653,089 | 30 | 2 |
| 2021-07-01 | RetinalGenix Technologies Inc. | Other Health Care | $7,000,000 | $45,000 | 3 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | RETINALGENIX TECHNOLOGIES INC. | FL | State business registries | EIN (EXACT, as the state registration reports it) |
| Form D issuer | RetinalGenix Technologies Inc. | FL | Form D private offerings | CIK (EXACT) |
| SEC filer | RETINALGENIX TECHNOLOGIES INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Retinalgenix Technologies Inc. | CA | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.